U.S. flag

An official website of the United States government

NM_130837.3(OPA1):c.1369G>A (p.Val457Met) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003556273.2

Allele description [Variation Report for NM_130837.3(OPA1):c.1369G>A (p.Val457Met)]

NM_130837.3(OPA1):c.1369G>A (p.Val457Met)

Gene:
OPA1:OPA1 mitochondrial dynamin like GTPase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q29
Genomic location:
Preferred name:
NM_130837.3(OPA1):c.1369G>A (p.Val457Met)
HGVS:
  • NC_000003.12:g.193643436G>A
  • NG_011605.1:g.55293G>A
  • NM_001354663.2:c.835G>A
  • NM_001354664.2:c.832G>A
  • NM_015560.3:c.1204G>A
  • NM_130831.3:c.1096G>A
  • NM_130832.3:c.1150G>A
  • NM_130833.3:c.1207G>A
  • NM_130834.3:c.1258G>A
  • NM_130835.3:c.1261G>A
  • NM_130836.3:c.1315G>A
  • NM_130837.3:c.1369G>AMANE SELECT
  • NP_001341592.1:p.Val279Met
  • NP_001341593.1:p.Val278Met
  • NP_056375.2:p.Val402Met
  • NP_056375.2:p.Val402Met
  • NP_570844.1:p.Val366Met
  • NP_570845.1:p.Val384Met
  • NP_570846.1:p.Val403Met
  • NP_570847.2:p.Val420Met
  • NP_570848.1:p.Val421Met
  • NP_570849.2:p.Val439Met
  • NP_570850.2:p.Val457Met
  • LRG_337t1:c.1204G>A
  • LRG_337:g.55293G>A
  • LRG_337p1:p.Val402Met
  • NC_000003.11:g.193361225G>A
  • NM_015560.2:c.1204G>A
Protein change:
V278M; VAL402MET
Links:
OMIM: 605290.0021; dbSNP: rs879255594
NCBI 1000 Genomes Browser:
rs879255594
Molecular consequence:
  • NM_001354663.2:c.835G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354664.2:c.832G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_015560.3:c.1204G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130831.3:c.1096G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130832.3:c.1150G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130833.3:c.1207G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130834.3:c.1258G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130835.3:c.1261G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130836.3:c.1315G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130837.3:c.1369G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004292250Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Mar 14, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Early-onset Behr syndrome due to compound heterozygous mutations in OPA1.

Bonneau D, Colin E, Oca F, Ferré M, Chevrollier A, Guéguen N, Desquiret-Dumas V, N'Guyen S, Barth M, Zanlonghi X, Rio M, Desguerre I, Barnerias C, Momtchilova M, Rodriguez D, Slama A, Lenaers G, Procaccio V, Amati-Bonneau P, Reynier P.

Brain. 2014 Oct;137(Pt 10):e301. doi: 10.1093/brain/awu184. Epub 2014 Jul 10. No abstract available.

PubMed [citation]
PMID:
25012220

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004292250.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt OPA1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 225122). This variant is also known as c.1369G>A. This missense change has been observed in individual(s) with OPA1-related conditions (PMID: 25012220). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 402 of the OPA1 protein (p.Val402Met).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024